Case Report of patient RE Submitted by:Jesse M Proett, MS4 Faculty reviewer:Sandra Oldham, M.D Date accepted:29 August 2007 Radiological Category:Principal.

Slides:



Advertisements
Similar presentations
Ultrasonography The Spleen VCA 341 Dr. LeeAnn Pack
Advertisements

Adrenal Masses: MR Imaging Features with Pathologic Correlation
GI12.  The liver has a dual blood supply, which comes from the hepatic artery ( 25% of vascularization) and the portal vein ( 75% of vascularization).
OSLER RENDU WEBER SYNDROME. AIM To diagnose a rare case of OSLER RENDU WEBER SYNDROME Screening methods for first degree relatives of patients for early.
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 5 The Liver Part I: Abdominal Sonography Abdomen and Superficial Structures.
Ayman Abdo MD, AmBIM, FRCPC
Maarten van Leeuwen, Joost Nederend and Robin Smithuis
Case Report # 1 Submitted by:Austen W. Worsham, MSIV Faculty reviewer: Dr. Oldham Date accepted: 8/29/2007 Radiological Category:Principal Modality (1):
FOCAL HEPATIC LESIONS IMAGING DIAGNOSIS
Liver Diseases.
Hepatobiliary pathology By Dr/ Dina Metwaly
Focal Lesions in the Cirrhotic Liver
Common Findings in Liver Imaging
CASE PRESENTATION By: Dr. SHAMSHAD KHAN TMO Radiology HMC.
MedPix Medical Image Database COW - Case of the Week Case Contributor: Brittany Ritchie Affiliation: National Capital Consortium.
Guzman, Alexander Joseph Hipolito, April Lorraine
Case Report Patient PP Submitted by:Matthew Clower, MSIV Faculty:Sandra Oldham, MD Date:29 August 2007 Radiological Category:Principal Modality (1): Principal.
Case Report Submitted by:Lucila Martinez CC4 Date accepted:August 29 th 2007 Radiological Category:Principal Modality (1): Principal Modality (2): Faculty.
Case Report # 1 Submitted by:James Korf, MS4 Faculty reviewer:Sandra Oldham, MD Date accepted:27 August 2014 Radiological Category:Principal Modality (1):
Hamid Tavakkoli, MD Associate Prof. of Gastroenterology.
Evaluating the Patient With Abnormal Liver Tests-2 פרופ ' צבי אקרמן מבית חולים הדסה הר הצופים.
Case Report # 1 Submitted by:Keith Pettibon Faculty reviewer:Sandra Oldham, MD Date accepted:24 August 2010 Radiological Category:Principal Modality (1):
Salzburg Weill Cornell Seminar in Diagnostic Imaging Hepatic tumors 9 – 15 October 2011, Salzburg, Austria Siarhei Kharuzhyk, M.D., Ph.D. N.N. Alexandrov.
Haemodynamic events and localised parenchymal changes following TACE for hepatic malignancy: interpretation of imaging findings The British Journal of.
SYB Case #2 Jordan Torok Class of 2010 December 11 th, 2008.
Student SYB Chet Cunha MS IV January 22, History 61 y/o M with known HCV x 5 yrs. presenting with vague abdominal discomfort. Outside CT showed.
Clinical History Patient presents with a palpable upper abdominal mass Patient states possible clinical history of abdominal hernia.
SONG QIANG Department of Radiology, Affiliated Hospital of Xuzhou Medical College Urinary tract and male reproductive system.
Digestive system Diagnostic imaging department of xuzhou medical college of xuzhou medical college.
 Macroscopic anatomy › External view › The quadrate lobe belongs anatomically to the right lobe and functionally to the left
Hamid Tavakkoli, MD Associate Prof. of Gastroenterology.
Bile ducts Caroli disease  Congenital  Dysplasia with focal dialatations.
Imaging of Focal Nodular Hyperplasia: A Review
Thomas Sersté1,2, Vincent Barrau3, Violaine Ozenne1, Marie Pierre Vullierme3, Pierre Bedossa5,6, Olivier Farges4, Dominique-Charles Valla1,6, Valérie Vilgrain3,6,
Michael J. Campbell, MD Virginia Mason Medical Center Seattle, Washington.
Dr. Ashraf Abdelfatah Faculty of Medicine
Liver mass Mazen Hassanain. Radiology Arterial enhancement: adenoma, FNH, hemangioma, HCC, NET mets Portal enhancement: CRC liver mets.
Differential Diagnosis
Benign Liver Masses in HIV Patient
Journal Reading Intern 陳盈元.
Radiology of hepatobiliary diseases
NESIR case presentation
D.Ferguson, M.Mohammed, C. Healy, A.C. Harris, S Chang.
Nikhil Amesur, MD, John S. Hammond, MD, Albert B. Zajko, MD, David A
Various liver lesions. (A) Focal nodular hyperplasia in the liver presenting as a hypoechoic lesion (arrow). (B) Hemangioma with characteristic hyperechoic.
LIVER MRI Kyung Hee University Hospital Hyoung Jung Kim
CT of the abdomen.
Two lesions are seen within the lateral segment of the left lobe of the liver (yellow arrows). They appear mildly hyperintense on T2 images and mildly.
MR of Liver imaging :How I do it?
An avidly enhancing mass is seen in the left lobe on arterial-phase imaging. It is slightly hyperintense on portal-venous-phase imaging but overall isointense.
Chapter 13 Hepatic Tumors, Benign 1
Chapter 14 Hepatic Tumors, Malignant 1
Imaging Approach for Evaluation of Focal Liver Lesions
Liver Masses: A Clinical, Radiologic, and Pathologic Perspective
Oren Shaked, Evan S. Siegelman, Kim Olthoff, K. Rajender Reddy 
Annalisa K. Becker, MD, FRCPC, David K. Tso, MD, Alison C
Fig. 3. Sub-centimeter-sized HCC in 56-year-old man with chronic hepatitis B. Gadoxetic acid-enhanced MR image demonstrates 0.8-cm nodule (arrows) in right.
Primovist, Eovist: What to expect?
Volume 68, Issue 4, Pages (April 2018)
Case of the Month: November 2018
Magnetic resonance imaging of liver tumors
Riccardo Lencioni, Fabio Piscaglia, Luigi Bolondi 
Benign liver tumors: tips and tricks
Volume 65, Issue 2, Pages (August 2016)
Benign vs malignant collapse
Primovist, Eovist: What to expect?
Digital subtract angiography and lipiodol deposits following embolization in cirrhotic nodules of LIRADS category ≥3  Zhen Kang, Nan Wang, Anhui Xu, Liang.
CT-SCAN & MRI LIRADS 2018 Dr. NGUYỄN HỒ TRÚC LINH - MRI.
Fig. 6. Gadoxetic acid-enhanced MRI in 70-year-old woman with chronic hepatitis C.On fat-saturated T2-weighted image (A), approximately 5-cm mass (arrow)
Appearance of Focal Liver Lesions Using Contrast-Enhanced Magnetic Resonance Imaging Using Gadofosveset Trisodium, an Intravascular (Blood-Pool) Contrast.
Presentation transcript:

Case Report of patient RE Submitted by:Jesse M Proett, MS4 Faculty reviewer:Sandra Oldham, M.D Date accepted:29 August 2007 Radiological Category:Principal Modality (1): Principal Modality (2): Gastrointestinal Angiography MRI Presentation for Radiology 4001

Case History RE is a 62 yo man with cirrhosis and ESLD likely secondary to NASH and portal HTN. He has a MELD score of 18 and is currently on the liver transplant list. On his last appointment he was found to have an elevated AFP of (Ref Range <15). He had core needle biopsies of the liver on 5/4/2005 and also in 2001 in Denver. RE also had a jet ski accident in 1992 resulting in a leg fracture and additional traumas in 2002 and 2004 requiring hand and wrist surgery. There was no reported trauma to the liver other than the biopsies.

Radiological Presentations

Hepatocellular Carcinoma Hepatic Adenoma Hemangioma Focal Nodular Hyperplasia Hepatic Cysts Vascular Abnormality Which one of the following is your choice for the appropriate diagnosis? Test Your Diagnosis

The liver demonstrates a heterogeneous appearance, and there is some nodularity associated with its contour. Decreased intensity is noted in the left lobe in non- contrast, dynamic, and delayed images. On the dynamic images there is an area of blush seen near the dome. This is felt to represent an area of increased vascularity. There is no evidence of washout, enhancing capsule, or discrete mass lesion. The portal vein is enlarged measuring 16mm. Hepatocellular Carcinoma Hepatic Adenoma Hemangioma Focal Nodular Hyperplasia Vascular Abnormality Findings: Differentials: Findings and Differentials

Radiological Presentations

Hepatocellular Carcinoma Lesion must be larger than 3cm Hyperintense appearance in T2W images Intense enhancement in the arterial dominant phase Late washout Presence of capsule Tendency to invade the portal and hepatic veins Rapid growth Hepatic Adenoma MRI characteristics are highly variable Hyperintense on T1 and T2W images due to the presence of fat and/or glycogen Greater enhancement on T2W images with gadolinium is highly suggestive of the diagnosis Gadolinium enhancement is early, after which the lesion becomes isointense Discussion

Hemangioma Hypointense in T1W images Hyperintense in T2W images Smooth, well-demarcated borders Ring-like enhancement 1 minute after contrast is given Wash-out, which causes a heterogeneous appearance, and observation of a uniform, thick ring Focal Nodular Hyperplasia They are hypo- or isointense on T1W images Mildly hyper- or isointense on T2W images Rapid enhancement in the early arterial phase Washout in the late phase is observed Central scar tissue shows late enhancement Discussion

Vascular Abnormality MRI is not the ideal modality to diagnose vascular abnormalities Angiography is the gold standard for diagnosis. The decreased intensity in the left lobe of the liver through both non-contrast and contrast images does indicate a possible vasculature etiology The area of high intensity during the dynamic phase suggests increased vascularity with no evidence of a discrete mass Hepatic US showed no evidence of abnormal blood flow on 4/29/2005 before his core needle biopsy on 5/4/2005. Discussion

A diagnosis could not be made based on the MRI. Further evaluation is needed to rule out malignancy. A lipiodol study was ordered to visualize a possible HCC. Lipiodol is an embolic agent used in angiography that allows us to visualize HCC because the embolic agent stays in the mass. Discussion

Radiological Presentations

Intrahepatic Arterioportal Fistula (APF) Diagnosis

Etiology Acquired Trauma - blunt or penetrating Iatrogenic - interventional hepatic procedures, liver biopsies, percutaneous transhepatic cholangiography, ruptured splanchnic artery aneurysms, transhepatic catheterization of bile ducts Tumors - especially hepatocellular carcinoma Liver Transplant Other - Hemangiomas, cirrhosis, regenerating liver nodules, hepatic abscess, Budd- Chiari syndrome, hereditary hemorrhagic telangiectasia, and Ehlers-Danlos Congenital - typically presents very early in life (neonate – 10yo) Diagnosis

Liver biopsy - 52% of the patients who had an arteriogram performed within 1 week following liver biopsy. This rate decreased to 10% if the arteriogram was performed 3 weeks after liver biopsy. These data suggest most small, peripheral, asymptomatic fistulas caused by liver biopsy will disappear spontaneously within 1 month. Trauma - The majority of APFs are due to blunt or penetrating trauma. APFs develop more frequently from penetrating trauma. In some cases the traumatic event can be decades before the presentation of the APF. Cirrhosis - AFPs due to cirrhosis are more commonly peripheral and asymptomatic. Diagnosis

Ultrasound - US is a useful tool in screening patients with cirrhosis or those at risk of acquiring APFs. RE did have an US of his abdomen, and at that time there was no mention of an APF. Finding on his US on 4/29/2005 include portal vein 4.5mm with no detectable flow within the main portal vein. MRI - This is not a diagnostic study for the evaluation of APFs, but there are some subtle signs. APFs can induce focal sparing in the diffuse fatty liver through increased non-lipid-rich arterial flow and decreased lipid-rich portal flow. This means that in the area affected by the APF there can be decreased signal which is what we observed on MRI. Much in the same way gadolinium will also be shunted away from the areas affected by the APF. Angiography - This is the gold standard for diagnosing APFs. Contrast material is seen immediately entering the portal circulation. Diagnosis

Proposed Classification Type 1 - Small, peripheral, intrahepatic fistulas with minimal physiologic consequences - Commonly secondary to liver biopsy - Usually thrombose spontaneously 1mo and/or become symptomatic Type 2 - Larger, more central fistulas with enough flow to cause elevated portal pressures - Most are secondary to penetrating trauma - Cause portal hypertension and hepatoportal sclerosis and can progress to portal fibrosis - Treat with embolization if possible or surgery for complicated cases Type 3 - Diffuse intrahepatic APFs - Congenital - Cause severe portal hypertension in infancy - Refer to a specialized pediatric hepatobiliary center. Treatment may consist of hepatic artery ligation, embolization, resection, or liver transplantation Diagnosis

Radiological Presentations

1. Guzman EA, McCahill LE, Rogers FB. Arterioportal fistulas: introduction of a novel classification with therapeutic implications. J Gastrointest Surg 2006;10:543– Bilgili Y,Firat Z, Pamuklar E, et al. Focal liver lesions evaluated by MR imaging. Diagn Interv Radiol 2006; 12: Bolognesi M, et al. Arterioportal fistulas in patients with liver cirrhosis: usefulness of color doppler US for screening. Radiology 2000; 216:738– Choi BI, Lee KH, Han JK, Lee JM, et al. Hepatic arterioportal shunts: dynamic CT and MR features. Kor J Radiol 2002;3:1– UpToDate References